BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 33239065)

  • 1. Targeting autophagy to overcome drug resistance: further developments.
    Chang H; Zou Z
    J Hematol Oncol; 2020 Nov; 13(1):159. PubMed ID: 33239065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting autophagy to overcome drug resistance in cancer therapy.
    Kumar A; Singh UK; Chaudhary A
    Future Med Chem; 2015 Aug; 7(12):1535-42. PubMed ID: 26334206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β-asarone inhibited cell growth and promoted autophagy via P53/Bcl-2/Bclin-1 and P53/AMPK/mTOR pathways in Human Glioma U251 cells.
    Wang N; Zhang Q; Luo L; Ning B; Fang Y
    J Cell Physiol; 2018 Mar; 233(3):2434-2443. PubMed ID: 28776671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactive oxygen species regulation of autophagy in cancer: implications for cancer treatment.
    Li L; Ishdorj G; Gibson SB
    Free Radic Biol Med; 2012 Oct; 53(7):1399-410. PubMed ID: 22820461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoplasmic Reticulum Stress Promotes Autophagy and Apoptosis and Reduces Chemotherapy Resistance in Mutant p53 Lung Cancer Cells.
    Gan PP; Zhou YY; Zhong MZ; Peng Y; Li L; Li JH
    Cell Physiol Biochem; 2017; 44(1):133-151. PubMed ID: 29130967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural products targeting autophagy via the PI3K/Akt/mTOR pathway as anticancer agents.
    Sun H; Wang Z; Yakisich JS
    Anticancer Agents Med Chem; 2013 Sep; 13(7):1048-56. PubMed ID: 23293890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting autophagic pathways for cancer drug discovery.
    Liu B; Bao JK; Yang JM; Cheng Y
    Chin J Cancer; 2013 Mar; 32(3):113-20. PubMed ID: 22835386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Core signaling pathways of survival/death in autophagy-related cancer networks.
    Wang SY; Yu QJ; Zhang RD; Liu B
    Int J Biochem Cell Biol; 2011 Sep; 43(9):1263-6. PubMed ID: 21640844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AMPK activation induced by promethazine increases NOXA expression and Beclin-1 phosphorylation and drives autophagy-associated apoptosis in chronic myeloid leukemia.
    Medeiros HCD; Colturato-Kido C; Ferraz LS; Costa CA; Moraes VWR; Paredes-Gamero EJ; Tersariol ILS; Rodrigues T
    Chem Biol Interact; 2020 Jan; 315():108888. PubMed ID: 31682805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibiting autophagy to prevent drug resistance and improve anti-tumor therapy.
    Zamame Ramirez JA; Romagnoli GG; Kaneno R
    Life Sci; 2021 Jan; 265():118745. PubMed ID: 33186569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autophagy is a therapeutic target in anticancer drug resistance.
    Chen S; Rehman SK; Zhang W; Wen A; Yao L; Zhang J
    Biochim Biophys Acta; 2010 Dec; 1806(2):220-9. PubMed ID: 20637264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of autophagy and apoptosis in tumor].
    Tang JL; Zhang HH; Lai MD
    Zhonghua Bing Li Xue Za Zhi; 2012 Aug; 41(8):573-6. PubMed ID: 23157757
    [No Abstract]   [Full Text] [Related]  

  • 13. Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment.
    Sui X; Chen R; Wang Z; Huang Z; Kong N; Zhang M; Han W; Lou F; Yang J; Zhang Q; Wang X; He C; Pan H
    Cell Death Dis; 2013 Oct; 4(10):e838. PubMed ID: 24113172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulating autophagy: a strategy for cancer therapy.
    Li JL; Han SL; Fan X
    Chin J Cancer; 2011 Oct; 30(10):655-68. PubMed ID: 21959043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer-type-specific crosstalk between autophagy, necroptosis and apoptosis as a pharmacological target.
    Radogna F; Dicato M; Diederich M
    Biochem Pharmacol; 2015 Mar; 94(1):1-11. PubMed ID: 25562745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PBK, targeted by EVI1, promotes metastasis and confers cisplatin resistance through inducing autophagy in high-grade serous ovarian carcinoma.
    Ma H; Li Y; Wang X; Wu H; Qi G; Li R; Yang N; Gao M; Yan S; Yuan C; Kong B
    Cell Death Dis; 2019 Feb; 10(3):166. PubMed ID: 30778048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibiting autophagy overcomes docetaxel resistance in castration-resistant prostate cancer cells.
    Wang Q; He WY; Zeng YZ; Hossain A; Gou X
    Int Urol Nephrol; 2018 Apr; 50(4):675-686. PubMed ID: 29460131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploiting the potential of autophagy in cisplatin therapy: A new strategy to overcome resistance.
    García-Cano J; Ambroise G; Pascual-Serra R; Carrión MC; Serrano-Oviedo L; Ortega-Muelas M; Cimas FJ; Sabater S; Ruiz-Hidalgo MJ; Sanchez Perez I; Mas A; Jalón FA; Vazquez A; Sánchez-Prieto R
    Oncotarget; 2015 Jun; 6(17):15551-65. PubMed ID: 26036632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autophagy facilitates lung adenocarcinoma resistance to cisplatin treatment by activation of AMPK/mTOR signaling pathway.
    Wu T; Wang MC; Jing L; Liu ZY; Guo H; Liu Y; Bai YY; Cheng YZ; Nan KJ; Liang X
    Drug Des Devel Ther; 2015; 9():6421-31. PubMed ID: 26715839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AMPK and Cancer.
    Wang Z; Wang N; Liu P; Xie X
    Exp Suppl; 2016; 107():203-226. PubMed ID: 27812982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.